Legal Representation
Attorney
R. GWEN PETERSON
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 4, 2005 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 4, 2005 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 28, 2005 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Feb 28, 2005 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 7, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jan 19, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 19, 2005 | I | PAPER RECEIVED | Loading... | |
| Jul 13, 2004 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 17, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jun 17, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 17, 2004 | I | PAPER RECEIVED | Loading... | |
| Jan 6, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely gene therapy for protein deficiencies, orally delivered small molecule drugs, DNA therapeutics delivered via an endoseopic procedure to the liver,protein therapeutics delivered orally, DNA therapeutics delivered to the intestine and oral DNA vaccines delivered to the intestine;materials and compounds for use as components of, or in manufacturing, pharmaceuticals; pharmaceutical delivery platforms, namely oral and liver drug delivery systems comprised of genes encoding systemic proteins
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005